Intramuscular hydroxocobalamin injections are the UK first-line treatment for pernicious anaemia and neurological B12 deficiency
Key Phase 2 conjugation pathways include: Glutathione Conjugation Binding reactive metabolites to glutathione, facilitating detoxification while protecting cellular structures from oxidative injury
No Artificial Color, Flavor, or Sweetener, No Preservatives, No Sugar, No Milk, No Corn, No Soy, No Egg, No Lactose, No Gluten
Further robust clinical investigations to conclusively ascertain the chemotherapeutic potential of SFN in the management of various cancer forms are needed
Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis